RecruitingNot ApplicableNCT05824520

Coronary CT-Derived FFR-Guided Strategy Versus Medical Therapy

Coronary Computed Tomography-Derived Fraction Flow Reserve (FFR)-Guided Invasive Treatment Strategy (ITS) Versus Optimal Medical Therapy (OMT) Alone in Patient With Chronic Coronary Syndrome

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine

Enrollment

1,066 participants

Start Date

Oct 10, 2024

Study Type

INTERVENTIONAL

Conditions

Myocardial ischaemia Coronary Artery Disease

Summary

The overall purpose of ACCURATE II trial is to compare the clinical outcomes of CT-derived FFR guided strategy versus medical therapy in patients with chronic coronary syndrome.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying ITS plus OMT and OMT for people with coronary artery disease and myocardial ischaemia. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERITS plus OMT

Invasive treatment strategy plus optimal medical therapy

OTHEROMT

Optimal medical therapy alone

Locations(1)

Second Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05824520

Related Trials

Product Surveillance Registry

NCT01524276400 locations

OPTIMIZE-APT: Tailored Versus Conventional Antiplatelet Therapy After Intravascular Imaging-guided Drug-eluting Stent Implantation

NCT0541855633 locations